Subretinal recombinant human tissue plasminogen activator injection using a 41G needle for the management of submacular hemorrhages: a 3-case report

Subretinal recombinant human tissue plasminogen activator injection using a 41G needle for the management of submacular hemorrhages: a 3-case report

Bibliographic Details
Main Authors:	Dan Jiang, Zhi-Xiang Hu, Xiao-Ling Yang, Qi-Fei Shang, Rong-Han Wu
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2023-04-01
Series:	International Journal of Ophthalmology
Online Access:	http://ies.ijo.cn/en_publish/2023/4/20230424.pdf

Similar Items

Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept
by: Yunxi Ma, et al.
Published: (2024-09-01)

Three-dimensional heads-up system assisted pars plana vitrectomy and subretinal recombinant tissue plasminogen activator injection for submacular hemorrhage
by: Xinyu Zhao, et al.
Published: (2023-03-01)

Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator
by: Maasa Ogata, et al.
Published: (2022-12-01)

Surgical Removal of Submacular Perfluorocarbon Liquid Using a 41-Gauge Extendible Subretinal Injection Needle
by: Khalil Ghasemi Falavarjani, et al.
Published: (2019-07-01)

Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series
by: Direk Patikulsila, et al.
Published: (2022-10-01)

Outcomes of pars plana vitrectomy with subretinal tissue plasminogen activator injection and pneumatic displacement of fovea-involving submacular haemorrhage
by: Richard B Rosen, et al.
Published: (2020-10-01)

Tissue Plasminogen Activator Toxicity after Submacular Hemorrhage Repair
by: Yasmin Islam, et al.
Published: (2021-07-01)

Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
by: Agnieszka Nowosielska, et al.
Published: (2024-03-01)

Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
by: Remzi Avcı, et al.
Published: (2021-01-01)

Intravitreous Recombinant Tissue Plasminogen Activator and Gas to Treat Submacular Hemorrhage in Age-Related Macular Degeneration
by: San-Chang Tsai, et al.
Published: (2003-12-01)

The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
by: A. D. Ovchinnikova, et al.
Published: (2021-01-01)

Tissue plasminogen activator-assisted surgical removal of massive subretinal hemorrhage
by: G Mahesh, et al.
Published: (2020-01-01)

A novel technique for extensive submacular hemorrhage using high-dose tissue plasminogen activator
by: Khushboo Chauhan, et al.
Published: (2024-05-01)

Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
by: Annekatrin Rickmann, et al.
Published: (2021-01-01)

Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
by: Yasmin Ali Said, et al.
Published: (2021-01-01)

Correlation between subretinal tissue plasminogen activator and air injection rates with pressure in a retina mimicking model
by: Na Hee Kim, et al.
Published: (2024-10-01)

Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.
by: Chutithep Teekaput, et al.
Published: (2022-01-01)

Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage
by: Chutithep Teekaput, et al.
Published: (2022-01-01)

Submacular hemorrhage secondary to congenital toxoplasmosis
by: Ana Luiza Fontes de Azevedo Costa, et al.

Traumatic Submacular Hemorrhage with Macular Hole Repaired by Pneumatic Displacement and Intravitreal t-PA Injection
by: Amy A. Mehta, et al.
Published: (2017-01-01)

Pneumatic Displacement with Perfluoropropane Gas and Intravitreal Tissue Plasminogen Activator for Subretinal Subfoveal Hemorrhage after Focal Laser Photocoagulation in Central Serous Chorioretinopathy
by: Khalid Al Rubaie, et al.
Published: (2014-01-01)

Intracranial hemorrhage after recombinant tissue plasminogen Activator: The competing risks survival analysis
by: Waitayaporn Pengtong, et al.
Published: (2023-06-01)

Role of fundus autofluorescence imaging in the management of submacular hemorrhage
by: Ramesh Venkatesh, et al.
Published: (2024-10-01)

Intravitreal tPA Injection and Pneumatic Displacement for Submacular Hemorrhage in a 10-Year-Old Child
by: Takayuki Tsuyama, et al.
Published: (2016-01-01)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
by: Ramin Nourinia, et al.
Published: (2010-01-01)

Intravitreal r-tPA Injection and Pneumatic Displacement for Submacular Retinal Hemorrhage: A Case Series
by: Filippo Confalonieri, et al.
Published: (2022-08-01)

Submacular surgery.
by: Maaijwee, K, et al.
Published: (2006)

Submacular surgery
by: Saxena Sandeep, et al.
Published: (1997-01-01)

Valsalva Retinopathy Presenting as Subretinal Hemorrhage
by: Lívia Conci, et al.
Published: (2024-01-01)

Postoperative Multimodal Analysis in Successful Gas Displacement of a Submacular Hemorrhage
by: Tatiana Urrea-Victoria, et al.
Published: (2021-01-01)

Incidence of macular hole in patients undergoing pars plana vitrectomy for submacular hemorrhage.
by: Riko Matsumoto, et al.
Published: (2025-01-01)

An Innovatory Surgical Technique for Submacular Hemorrhage Displacement by Means of a Bioengineering Perspective
by: George Pappas, et al.
Published: (2021-05-01)

A Case of Traumatic Submacular Hemorrhage Treated with tPA and Pneumatic Displacement
by: Lorenzo Motta, et al.
Published: (2023-11-01)

A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke
by: Run-Hao Jiang, et al.
Published: (2019-06-01)

Submacular surgery - Reply
by: Maclaren, R, et al.
Published: (2006)

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial
by: Timothy L. Jackson, et al.
Published: (2022-01-01)

Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
by: Yan‐Qin Geng, et al.
Published: (2024-06-01)

Contemporary approach to the surgical management of traumatic submacular hemorrhage with choroidal rupture (case series)
by: A.V. Seleznev, et al.
Published: (2024-06-01)

Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series
by: Somnath Chakraborty, et al.
Published: (2022-11-01)

Possible synergism of tissue plasminogen activator and neurocysticercosis leading to intracranial hemorrhage
by: Ravi Rajmohan, et al.
Published: (2023-03-01)